Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients

Bibliográfalaš dieđut
Váldodahkkit:	Sergijenko, A, Moiseenko, A, Pineault, K, Nafchi, NAM, Chan, M, Gamlen, T, Gill, D, Hyde, S, Kreuz, S, Griesenbach, U, Alton, EWFW
Materiálatiipa:	Conference item
Giella:	English
Almmustuhtton:	Wiley 2020

Geahča maid

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
Dahkki: Sergijenko, A, et al.
Almmustuhtton: (2021)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
Dahkki: Griesenbach, U, et al.
Almmustuhtton: (2012)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
Dahkki: Griesenbach, U, et al.
Almmustuhtton: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
Dahkki: Griesenbach, U, et al.
Almmustuhtton: (2012)

Towards a first-in-human trial with a pseudotyped lentivirus
Dahkki: Alton, EW, et al.
Almmustuhtton: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
Dahkki: Sinadinos, A, et al.
Almmustuhtton: (2020)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
Dahkki: Hyde, S, et al.
Almmustuhtton: (2015)

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment
Dahkki: Sinadinos, A, et al.
Almmustuhtton: (2021)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
Dahkki: Davies, G, et al.
Almmustuhtton: (2011)

Development of protocols for mouse GLP-toxicology studies
Dahkki: Sinadinos, A, et al.
Almmustuhtton: (2020)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
Dahkki: Munday, RJ, et al.
Almmustuhtton: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
Dahkki: Munday, RJ, et al.
Almmustuhtton: (2022)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
Dahkki: Munday, RJ, et al.
Almmustuhtton: (2022)

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
Dahkki: Griesenbach, U, et al.
Almmustuhtton: (2016)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
Dahkki: Rosie J. Munday, et al.
Almmustuhtton: (2022-09-01)

Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
Dahkki: Gamlen, T, et al.
Almmustuhtton: (2020)

A Functional <it>Henipavirus </it>Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Dahkki: Broder Christopher C, et al.
Almmustuhtton: (2010-11-01)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
Dahkki: Davies, J, et al.
Almmustuhtton: (2011)

Rapid determination of rSIV.F/HN lentiviral vector titre
Dahkki: Conway, CC, et al.
Almmustuhtton: (2020)

Assessment of CFTR function after gene transfer in vitro and in vivo.
Dahkki: Griesenbach, U, et al.
Almmustuhtton: (2008)

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
Dahkki: Alton, E, et al.
Almmustuhtton: (2016)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
Dahkki: Palau, H, et al.
Almmustuhtton: (2019)

Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Dahkki: Ferrari, S, et al.
Almmustuhtton: (2007)

Large-scale, high-throughput production of rSIV.F/HN vectors
Dahkki: Viegas, MFA, et al.
Almmustuhtton: (2020)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
Dahkki: Lund-Palau, H, et al.
Almmustuhtton: (2018)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
Dahkki: Sinadinos, A, et al.
Almmustuhtton: (2021)

CFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways
Dahkki: Min Wu, et al.
Almmustuhtton: (2024-04-01)

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
Dahkki: Francesca Saluzzo, et al.
Almmustuhtton: (2022-04-01)

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
Dahkki: Buqing Yi, et al.
Almmustuhtton: (2021-03-01)

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
Dahkki: Hyde, S
Almmustuhtton: (2013)

Eucalyptus Essential Oil Inhibits Cell Infection by SARS-CoV-2 Spike Pseudotyped Lentivirus
Dahkki: Sara Alonso Fernandez, et al.
Almmustuhtton: (2024-08-01)

Transgenesis and Genome Editing of Mouse Spermatogonial Stem Cells by Lentivirus Pseudotyped with Sendai Virus F Protein
Dahkki: Takashi Shinohara, et al.
Almmustuhtton: (2020-03-01)

Self-reactive CFTR T cells in humans: implications for gene therapy.
Dahkki: Calcedo, R, et al.
Almmustuhtton: (2013)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
Dahkki: Lund-Palau, H, et al.
Almmustuhtton: (2018)

Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles
Dahkki: Ian Helstrup Nielsen, et al.
Almmustuhtton: (2024-12-01)

CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
Dahkki: Sheylan D. Patel, et al.
Almmustuhtton: (2020-06-01)

Design and Development of a Pseudotyped-lentivirus for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Dahkki: Hadi Hassannia, et al.
Almmustuhtton: (2023-11-01)

Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
Dahkki: Davies, L, et al.
Almmustuhtton: (2008)

Gene therapy for respiratory diseases; progress and a changing context
Dahkki: Alton, EWFW, et al.
Almmustuhtton: (2020)

Expression of gain-of-function CFTR in cystic fibrosis airway cells restores epithelial function better than wild-type or codon-optimized CFTR
Dahkki: Maximillian Woodall, et al.
Almmustuhtton: (2023-09-01)